Pheiron

📍 New York City, United States🗓 Founded 2023👥 11 employees💰 Last funded Jun 2025
Biotechnology Research🌐 pheiron.com
Website LinkedIn
Pheiron is an AI research lab working towards a future of deterministic drug development. We are solving the hardest problem in drug development: anticipating what biology will work in humans. We are build causal foundation models of human biology to algorithmically underwrite biology risk, identify next-generation opportunities and pick winning mechanisms.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in Pheiron?
Pheiron has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Pheiron last raise funding?
The most recent investment in Pheiron recorded on gritt.io was in June 2025.
When was Pheiron founded?
Pheiron was founded in 2023.
What industry is Pheiron in?
Pheiron operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pheiron based?
Pheiron is headquartered in New York City, United States.